Praxis Precision Medicines Inc Earnings

The next earnings date for Praxis Precision Medicines Inc is November 5, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Praxis Precision Medicines Inc Earnings

Report Date	Estimated Earnings Per Share
11/05/2025	$-3.39

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Praxis Precision Medicines Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/04/2025	---	$-3.31	-1.85%
05/12/2025	Before Market	$-3.29	-58.94%
03/03/2025	Before Market	$-2.94	-4.29%
11/05/2024	Before Market	$-2.75	-38.19%
08/13/2024	Before Market	$-1.74	24.68%
05/13/2024	Before Market	$-2.84	-36.54%
03/05/2024	Before Market	$-2.97	6.60%
11/07/2023	Before Market	$-0.18	48.57%
08/09/2023	Before Market	$-0.49	25.76%
05/11/2023	Before Market	$-0.71	10.13%
02/07/2023	Before Market	$-0.87	-11.54%
11/09/2022	After Market	$-0.96	-7.87%
08/08/2022	After Market	$-1.32	-1.54%
05/09/2022	After Market	$-1.51	-16.15%
02/28/2022	Before Market	$-1.30	-20.37%
11/03/2021	Before Market	$-1	-7.53%
08/16/2021	Before Market	$-0.88	-31.34%
05/11/2021	Before Market	$-0.71	4.05%
03/17/2021	Before Market	$-0.87	-135.14%
11/23/2020	After Market	$-12.10	-1,557.53%
09/02/2020	---	$-3.90	---

More About Praxis Precision Medicines Inc

Website

https://praxismedicines.com

Country

USA

Full Time Employees

116

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance. The company's platforms include cerebrum, a small molecule platform for CNS small molecule therapies to develop orally available precision therapies; and solidus to discover and develop antisense oligonucleotide. It also develops Ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase 3 clinical trial for the treatment of essential tremor; Vormatrigine, a small molecule targeting the hyperexcitable state of sodium-channels in the brain to treat focal onset epilepsy; Relutrigine for the treatment of developmental and epileptic encephalopathies; PRAX-020 to treat KCNT1; and PRAX-050. In addition, the company develops Elsunersen, a clinical-stage ASO designed to regulate NaV1.2 expression for the treatment of SCN2A-DEE; PRAX-080 that targets PCDH19-related developmental epilepsy; PRAX-090 for targeting SYNGAP1 loss-of-function; and PRAX-100 that targets SCN2A LoF mutations. It has a license agreement with RogCon Inc.; and research collaboration and license agreement with Ionis Pharmaceuticals, Inc. Praxis Precision Medicines, Inc. was incorporated in 2015 and is based in Boston, Massachusetts.

“Praxis Precision Medicines Inc Earnings” Can Refer to the Praxis Precision Medicines Inc Earnings Date

Some people say “Praxis Precision Medicines Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Praxis Precision Medicines Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Praxis Precision Medicines Inc Stock on the Earnings Date

If you own Praxis Precision Medicines Inc stock (PRAX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Praxis Precision Medicines Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Praxis Precision Medicines Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Praxis Precision Medicines Inc Earnings

You can contact us any time if you would like to ask questions about Praxis Precision Medicines Inc earnings or anything else related to the stock market.